There are 3161 resources available
1369P - Trilaciclib combined with intraventricular injection chemotherapy in the treatment of advanced NSCLC with leptomeningeal metastasis: A prospective, single-arm, phase II clinical trial
Presenter: Shen Cun Fang
Session: Poster session 06
1370P - Survival of de novo metastatic non-small cell lung cancer according to biomarker status in Denmark and Norway: A register-based cohort study
Presenter: Johan Liseth Hansen
Session: Poster session 06
1372P - Advanced non-small cell lung carcinoma in the era of immunotherapy: Survival and the risk of multiple primary malignancies
Presenter: Nahla Ali
Session: Poster session 06
1373P - Measuring PFS in clinical trials and observational studies of patients with NSCLC: A scoping review
Presenter: Marjon Verschueren
Session: Poster session 06
1374P - Analysis of evolution of patient reported side effects during treatment for advanced NSCLC
Presenter: Helena Linardou
Session: Poster session 06
1375P - Sequential ctDNA profiling in patients with advanced non-small cell lung cancer: An interim analysis of the COPE randomized study
Presenter: Antoine Italiano
Session: Poster session 06
Resources:
Abstract
1376P - Early detection of disease progression in NSCLC patients undergoing immunotherapy through ctDNA analysis
Presenter: Virginia Calvo de Juan
Session: Poster session 06
1377P - Association of anatomic proximity of brain parenchymal metastasis to the CSF space and upfront stereotactic radiosurgery to subsequent leptomeningeal metastasis development in brain metastatic NSCLC
Presenter: Shoaib Bashir
Session: Poster session 06
Resources:
Abstract
1378P - Improvements in stage IV non-small cell lung cancer survival differ by race in the US
Presenter: Oluwaseun Ayoade
Session: Poster session 06